Varenicline in Drug Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Smoking CessationAlcohol Abuse
Interventions
DRUG

varenicline

one 0.5mg varenicline capsule on first 3 days one 0.5mg varenicline capsule, twice daily for 4 days one 1.0mg varenicline capsule, twice daily until end of treatment (12weeks of medication

DRUG

placebo

lactose filler in capsules identical to the varenicline capsules one 0.5mg capsule for 3 days one 0.5mg capsule twice daily for 4 days one 1.0mg capsule twice daily until end of treatment (12weeks of medication)

Trial Locations (1)

M5T 1P7

Centre for Addiction and Mental Health, Nicotine Dependence Clinic, Toronto

All Listed Sponsors
collaborator

Ontario Lung Association

OTHER

lead

Centre for Addiction and Mental Health

OTHER

NCT01286584 - Varenicline in Drug Treatment | Biotech Hunter | Biotech Hunter